SVA

Sernova (SVA)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:SVA
DataOraFonteTitoloSimboloCompagnia
02/06/202217:00PR Newswire (Canada)Sernova Opens the MarketTSXV:SVASernova Corp
10/01/202215:48PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - SVATSXV:SVASernova Corp
10/01/202215:46PR Newswire (Canada)IIROC Trading Resumption - SVATSXV:SVASernova Corp
10/01/202215:44PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - SVATSXV:SVASernova Corp
10/01/202215:41PR Newswire (Canada)IIROC Trading Halt - SVATSXV:SVASernova Corp
04/02/202115:44PR Newswire (Canada)Sernova Upsizes Previously Announced Bought Deal Public Offering to C$20 MillionTSXV:SVASernova Corp
03/02/202123:20PR Newswire (Canada)Sernova Corp. Announces C$10 Million Bought Deal Offering of UnitsTSXV:SVASernova Corp
18/06/202018:58InvestorsHub NewsWirePURA SVA - Health Stocks Exhibit Healthy News, Robust Share HikesTSXV:SVASernova Corp
24/10/201913:30PR Newswire (Canada)Sernova Announces Biotech Veteran as New Chief Financial OfficerTSXV:SVASernova Corp
16/10/201918:55InvestorsHub NewsWireSernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in Phase I/II Clinical Trial for Type-ATSXV:SVASernova Corp
11/04/201918:14InvestorsHub NewsWireSernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical StudyTSXV:SVASernova Corp
05/07/201816:50InvestorsHub NewsWireSernova Initiates Patient Screening and Recruitment for its US Clinical Trial for DiabetesTSXV:SVASernova Corp
22/02/201814:35InvestorsHub NewsWireSernova's Cell Pouch Regenerative Medicine Clinical Trial for Type 1 Diabetes Supported with CGM SystemsTSXV:SVASernova Corp
11/12/201713:56InvestorsHub NewsWireSernova Receives US FDA IND Allowance to Initiate a US Clinical Trial of its Cell Pouch for the Treatment of Type 1 DiabetesTSXV:SVASernova Corp
15/07/201412:00Marketwired CanadaSernova Agrees on Terms to Gain Access to Proprietary Stem Cell Technology For the Treatment of DiabetesTSXV:SVASernova Corp
24/06/201412:00MarketwiredSernova Team Participates at Key US Life Sciences Event: 2014 BIO International Convention, San DiegoTSXV:SVASernova Corp
20/06/201412:00MarketwiredSernova's CEO Dr. Philip Toleikis Featured on BNNTSXV:SVASernova Corp
03/06/201412:00MarketwiredSernova Provides Corporate Update and Results of 2014 Annual General MeetingTSXV:SVASernova Corp
14/05/201412:00MarketwiredSernova Receives Patent Allowance for Cell Pouch(TM) and Therapeutic Cell Transplantation TechnologiesTSXV:SVASernova Corp
12/05/201412:00MarketwiredKevin Egan Joins Sernova as Chair Business Advisory BoardTSXV:SVASernova Corp
07/05/201412:00MarketwiredSernova Announces Appointment of Nick Borrelly to Corporate Development RoleTSXV:SVASernova Corp
22/04/201412:00Marketwired CanadaSernova's Cell Pouch(TM) Diabetes Clinical Trial Demonstrates Interim Safety and BiocompatibilityTSXV:SVASernova Corp
26/02/201412:00MarketwiredSernova Announces Annual Meeting, Record Date and Adopts Advance Notice By-LawTSXV:SVASernova Corp
11/02/201412:00MarketwiredFrank Holler Joins Sernova's Board of DirectorsTSXV:SVASernova Corp
31/01/201412:00MarketwiredSernova Announces Appointment of Cathy Steiner as CFOTSXV:SVASernova Corp
13/01/201412:00MarketwiredSernova to Present Company and Clinical Update at Biotech Showcase(TM) Healthcare Conference in San FranciscoTSXV:SVASernova Corp
27/11/201311:00Marketwired CanadaSernova Corp Engages Carson Seabolt and Network IRTSXV:SVASernova Corp
26/09/201319:00Marketwired CanadaWorld First: Sernova's Cell Pouch(TM) Shown to Provide a Safe Environment for Therapeutic Insulin Producing Islets in Humans ...TSXV:SVASernova Corp
11/09/201312:00Marketwired CanadaSernova Corp Engages Ray Matthews & AssociatesTSXV:SVASernova Corp
04/09/201312:00Marketwired CanadaSernova to Present at 15th Annual Rodman & Renshaw Global Investment ConferenceTSXV:SVASernova Corp
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:SVA
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network